Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Esophageal Neoplasms 5Carcinoma, Hepatocellular 4Liver Neoplasms 3Cholangiocarcinoma 2Resected Pancreatic Adenocarcinoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Carcinoma, Squamous Cell 1Anus Neoplasms 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Cisplatin 116Radiotherapy 84Paclitaxel 77Fluorouracil 62Carboplatin 41Drug Therapy 38pembrolizumab 33Irinotecan 33tislelizumab 27Docetaxel 26Neoadjuvant Therapy 24Oxaliplatin 23toripalimab 22sintilimab 19camrelizumab 19Radiation 19Esophagectomy 18Capecitabine 17130-nm albumin-bound paclitaxel 17Surgical Procedures, Operative 16Nivolumab 16Leucovorin 15Cetuximab 14TP protocol 12S 1 (combination) 12Radiotherapy, Intensity-Modulated 12Albumin-Bound Paclitaxel 12nimotuzumab 11apatinib 10Immune Checkpoint Inhibitors 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Proton Therapy × Gastrointestinal × Clear all
NCT02023541 2015-04-07

Proton Beam Therapy to Treat Esophageal Cancer

Washington University School of Medicine

Phase 1 Terminated
3 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡